Page last updated: 2024-10-31

midazolam and Facial Neoplasms

midazolam has been researched along with Facial Neoplasms in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Facial Neoplasms: New abnormal growth of tissue in the FACE.

Research Excerpts

ExcerptRelevanceReference
"Heat facial hyperalgesia was assessed on day 6 after the inoculation, and on this time point rats were submitted to the elevated plus maze and the light-dark transition tests."1.43Evaluation of heat hyperalgesia and anxiety like-behaviors in a rat model of orofacial cancer. ( Chichorro, JG; Dos Reis, RC; Gambeta, E; Kopruszinski, CM; Zanoveli, JM, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gambeta, E1
Kopruszinski, CM1
Dos Reis, RC1
Zanoveli, JM1
Chichorro, JG1

Other Studies

1 other study available for midazolam and Facial Neoplasms

ArticleYear
Evaluation of heat hyperalgesia and anxiety like-behaviors in a rat model of orofacial cancer.
    Neuroscience letters, 2016, Apr-21, Volume: 619

    Topics: Analgesics; Animals; Anti-Anxiety Agents; Anxiety; Cell Line, Tumor; Facial Neoplasms; Hot Temperatu

2016